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Abstract
Background: With the increase in the elderly population, a growing number of chronic degenerative diseases and
a greater dependency on caregivers have been observed. Elderly persons in states of frailty remain more
susceptible to significant health complications. There is evidence of an inverse relationship between plasma levels
of inflammatory mediators and levels of functionality and muscle strength, suggesting that muscle-strengthening
measures can aid in inflammatory conditions. The purpose of this study will be verified the effect of a muscle-
strengthening program with load during a ten-week period in pre-frail elderly women with attention to the
following outcomes: (1) plasma levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-a), (2) functional
capacity and (3) knee extensor muscle strength.
Methods/Design: The study design is a randomized crossover clinical trial evaluating 26 elderly women (regardless
of their race and/or social condition) who are community residents, older than 65, and classified as pre-frail
according to the criteria previously described by Fried et al. (2004). All subjects will be assessed using the Timed
up and go and 10-Meter Walk Test functional tests. The plasma levels of IL-6 and TNF-a will be assessed by ELISA
(enzyme-linked immunosorbent assay) with high sensitivity kits (Quantikine®HS, R&D Systems Minneapolis, MN, U.S.).
Knee extensor muscle strength will be assessed using the Byodex System 3 Pro® isokinetic dynamometer at angular
speeds of 60 and 180°/s. The intervention will consist of strengthening exercises of the lower extremities at 50 to
70% of 1RM (maximal resistance) three times per week for ten weeks. The volunteers will be randomized into two
groups: group E, the intervention group, and group C, the control group that did not initiate any new activities
during the initial study period (ten weeks). After the initial period, group C will begin the intervention and group E
will maintain everyday activities without exercising. At the end of the total study period, all volunteers will be
reassessed.
Discussion: To demonstrate and discuss possible influences of load-bearing exercises on the modification of
plasma levels of IL-6 and TNF-a and in the functional performance of pre-frail elderly women.
Trial Registration: ISRCTN62824599
* Correspondence: leanismp.bh@terra.com.br
3Departamento de Fisioterapia da Universidade Federal de Minas Gerais,
Belo Horizonte, MG, Brazil
Lustosa et al. Trials 2010, 11:82
http://www.trialsjournal.com/content/11/1/82
TRIALS
© 2010 Lustosa et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Background
Changes in the world age pyramid are occurring rapidly,
such that the elderly population is projected to grow by
550,000 per year and increase to one million per year by
the year 2025 [1,2]. Aging is a multifaceted reality in
which genetic, biological, social, cultural and psychologi-
cal variables should be considered in the differing mani-
festations and outcomes [3]. Frailty is a syndrome of a
multifactorial nature, characterized by a reduction in
energy reserves and by a decreased resistance to stres-
sors, resulting in a cumulative decline of the physiologi-
cal systems, characterized by a trio of changes:
sarcopenia, neuroendocrine deregulation and immune
dysfunction [4]. Fried et al. (2001) proposed five criteria
for the diagnosis of frailty in the elderly [5]. Early identi-
fication of the pre-frail elderly is important in order to
institute therapeutic guidelines and interventions that
can possibly prevent or minimize the conditions inher-
ent to the state of pre-frailty, such as fluctuations in
health and the risk of acute clinical complications [3-5].
Current studies demonstrate that the elevation in pro-
inflammatory cytokines in the plasma of the elderly is
associated with the development of the frailty syndrome,
a reduction in mobility, and an inability to conduct the
activities of daily life, a reduction in muscle strength
and an increase in mortality [6-11].
Interleukin 6 (IL-6) is an expression in plasma
increases during physiological aging, probably due to the
reduction of sex hormones [3,12,13]. Tumor necrosis
factor alpha (TNF-a) participates in the innate acute
inflammatory response by inducing the secretion of che-
mokines, which stimulate a second wave of cytokines,
including IL-6, IL-8 and C-reactive protein [14,15].
Greiwe et al. (2001) inferred that the systematic pre-
sence of TNF-a may contribute to the loss of muscle
mass [16]. There is evidence that muscular modifica-
tions appear to be associated with high levels of pro-
inflammatory cytokines, especially IL-6 and TNF-a
[17,18].
Regular exercise has been indicated to promoting
muscle strength and functionality in the elderly and
helps reduce the levels of inflammatory mediators, with
a reduction in the deleterious consequences of these
cytokines on muscle loss [19-22]. However, the intensity,
duration of exercise and the type of muscle contraction
appear to be factors that influence this outcome, though
the exact mechanism is still undetermined [19,23].
There are some evidences that IL-6 could be produced
from muscle contractions and that its release was
dependent on the intensity of the muscle activity and
the number of muscle fibers involved in the contraction,
specifically the concentric and the eccentric contraction
[19]. In this case it could be called miokine. They
inferred that IL-6 release probably occurred through a
route independent of the release of TNF-a. This cascade
would result in the inhibition of the deleterious muscu-
lar effects caused by the TNF-a released systematically
during sub threshold chronic inflammation [19]. Feb-
braio et al. (2002) suggested that the release of IL-6
could be stimulated by calcium (Ca2+) as a means of
maintaining metabolism in homeostasis, specially in
eccentric and concentric contraction [23]. However,
there is still no scientific evidence concerning which
mode of muscle contraction–eccentric or concentric–is
optimal in promoting modifications in the plasma levels
of these cytokines [19,23]. For this reason, we would
like to know what happens to the new exercise program
with a concentric contraction.
Some exercise programs have been proposed with the
intent of minimizing the loss of muscle strength in the
elderly and its functional consequences [22,24-26]. In a
randomized clinical trial, Kryger et al. (2007) demon-
strated earlier gains in muscle strength in elderly per-
sons after the execution of an exercise program and
there was also an increase in the transverse section area
and in the percentage of type II fibers, as analyzed by a
muscular biopsy [27]. However, the release of inflamma-
tory mediators after this exercises programs is already
unclear. In relation to the inflammatory mediators,
Plomgaard et al. (2005) reported that IL-6 could be pro-
duced from muscle contractions and that its release was
dependent on the intensity of the muscle activity and
the number of muscle fibers involved in the contraction
[28]. They inferred that IL-6 release probably occurred
through a route independent of the release of TNF-a,
inducing anti-inflammatory activity by the release of IL-
1ra and IL-10.
Given this information, it can be postulated that inter-
ventions that promote the strengthening of large muscle
groups may modify the plasma levels of IL-6 and TNF-
a, as well as improve the activity and functional perfor-
mance of elderly persons [29,30]. These modifications
would be of great benefit in the prevention and treat-
ment of disease in the elderly, since many of their issues
initially manifest as a reduction in functional activity
and independence. However, the literature is unanimous
in pointing out that new studies should be conducted to
verify the type of muscle contraction and the ideal
intensity and duration of an exercise program to
increase muscle strength, and to investigate its impact
on the plasma levels of IL-6 and TNF-a and functional-
ity in the elderly. The rationale is to propose kine-
siotherapeutic interventions that can promote the
improvement of muscle strength while decreasing the
release of inflammatory mediators, sarcopenia and func-
tional disability. Intervening in this cycle will possibly
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contribute towards improved functional performance of
daily activities, a reduced risk of falling, improvement in
the quality of life and a reduced risk of the frailty
syndrome.
Thus, this randomized crossover clinical trial was pro-
posed with the objective of verifying the effect of a pro-
gram of muscle strengthening with load during a ten
week period in pre-frail elderly women with attention to
the following outcomes: (1) functional ability, (2) knee
extensor muscle strength and (3) plasma levels of IL-6
and TNF-a. The study hypothesis is grounded in the
assumption that exercising with 75% of the maximum
load at a frequency of three times per week for 10
weeks may be sufficient to provide strength gains, and
consequently improve functional ability and reduce the
plasma levels of IL-6 and TNF-a.
This project has financial support from the Conselho
Nacional de Desenvolvimento Científico e Tecnológico -
CNPq, Brasília, Brasil.
Clinical Trial Registration: ISRCTN62824599.
Methods/Design
The general objective of the study will be verified the
effect of a program of resistance exercises at 75% RM
on the functional capacity, knee extensor muscle
strength, and to measure the plasma levels of IL-6 and
sTNFr in pre-frail elderly women.
Questions/Hypotheses
1. Among pre-frail elderly women, will changes
occur in the plasma levels of the inflammatory med-
iators IL-6 and sTNFr, functional capacity and knee
extensor muscle strength after completing a program
of resistance exercises at 75% of 1RM, three times a
week, for 10 weeks?
2. In a follow-up three months after finishing the
training, will there be modifications in the functional
capacity, knee extensor muscle strength and the
plasma levels of IL-6 and sTNFr in pre-frail elderly
women?
3. Is there a correlation between functional capacity,
knee extensor muscle strength and plasma levels of
IL-6 and sTNFr before and after a training program
with load in pre-frail elderly women?
The study design is a blind randomized crossover clin-
ical trial. Participants will be recruited from two univer-
sities. An initial assessment will be undertaken after
recruitment and prior to randomization into either
experimental or control group. Participants in the
experimental group will receive an exercise program,
three times a week, during ten weeks. Participants in the
control group will receive no physiotherapy intervention.
Outcomes will be measured again after ten weeks to
reflect the immediate effect of the intervention. Then,
the experimental group will receive no physiotherapy
intervention and the control group will receive the same
exercise program. Outcomes will be measured again to
reflect longer-term outcomes from experimental group
and the immediate effect of the intervention in the con-
trol group (Figure 1). This allows verification of the
existence of a change and/or variable correlations speci-
fically due to the intervention, and not due to the time
factor and/or changes in the aging process. Furthermore,
it allows verification of the existence of variable changes
after finishing the training. Additionally, from an ethical
point of view, it guarantees that the volunteers receive
the same treatment. The outcome measures will be col-
lected by a physiotherapist who was blind to group allo-
cation. The responsible for the intervention will not
know about the assessment. The study was approved by
the ethical committee of the university and informed
consent procedures were taken.
Sample
Twenty-six women, regardless of their race and/or social
class, above the age of 65 who are community residents
and classified as pre-frail according to the criteria estab-
lished by Fried et al. (2001) will be selected for inclusion
in the study. These volunteers will be randomly divided
into two groups (control = C and experimental = E) of
13 volunteers each. This population was chosen based
upon the assumption that pre-frail elderly people appear
to respond better to interventions, resulting in a greater
possibility of modifications that influence muscle
response.3 Demographic characteristics (age, race, school
level, height, weight and body mass index) will be col-
lected from all the participants.
Elderly women who meet one or more of the follow-
ing criteria will be excluded from the study: previous
lower extremities orthopedic surgery, a history of frac-
tures within the past year, an inability to walk unaided,
carriers of neurological diseases, diagnosed acute inflam-
matory disease that could interfere in the assessments
and the program, tumor growth in the last five years,
current use of immunomodulating medications and cog-
nitive impairment based on the mini-mental state exam-
ination [31].
Primary outcome
Plasma levels of IL-6 and TNF-a will be determined
using the ELISA (enzyme-linked immuno sorbent assay)
method with high sensitivity kits (Quantikine®HS, R&D
Systems Minneapolis, USA). Samples will be read with
an adjusted microplate reader for 490 nm and wave-
length correction to 650 nm. TNF-a acts at two known
receptors: TNFR1 and TNFR2. In humans, the measure
of circulating levels of the two soluble receptors is useful
Lustosa et al. Trials 2010, 11:82
http://www.trialsjournal.com/content/11/1/82
Page 3 of 7
in determining the global production of TNF-a in
plasma [32].
Secondary outcomes
For functional performance, the Timed Up and Go
(TUG) test [25,30,33] and the 10-Meter Walk Test
(10MWT) will be used [34]. The TUG test has a high
test-retest and inter-examiner reliability (ICC = 0.99, r =
0.93) [35]. Skinkai (2000) asserted that the 10MWT is
the greatest predictor of falls and functional dependency
in the elderly [34].
Knee extensor muscle strength will be evaluated with
the Biodex system 3 Pro® isokinetic dynamometer at
angular speeds of 60 and 180°/s. This equipment is cap-
able of evaluating muscle function in concentric,
eccentric and isometric modes at angular speeds of 2 to
420°/s. It will be used to measure the maximum work
produced by the knee extensor muscle group normalized
to body weight in the concentric and at angular speeds of
60 and 180°/s. Peak torque and potential at these speeds
will also be assessed. The advantages of using an isoki-
netic dynamometer include using the same resistance at
one constant speed of motion, a high reliability in the
measures and a correlation between the torque, work and
potential parameters (ICC = 0.99, p < 0.01) [35].
Randomization
After the initial evaluation, the volunteers will be rando-
mized into either group E or group C. This randomiza-
tion will take place with an equal number of envelopes.
Figure 1
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The researcher responsible for the evaluations will be
blinded to the participants’ group. The researcher
responsible for the intervention will be blinded to the
assessment results until the final data collection.
Intervention
The volunteers in experimental group will begin the
physical activity program of exercises conducted in
small groups with direct instruction from the physical
therapist for one hour, three times per week for a period
of ten weeks. The large muscle groups of the lower
extremities (hip flexors and extensors, knee flexors and
extensors and plantar flexors) will be exercised on an
open and closed kinetic chain. The appropriate weight
for each volunteer will be determined by calculating the
percent of maximum load (1RM) [25]. The choice of
concentric exercises was based upon literature which
has indicated that this activity in the large muscle
groups induces and modifies the production of IL-6 and
TNF-a [3,12,19,28]. Semi-squats are used for their
increased functional benefits and because they decrease
the compression forces on the patellofemoral joint,
thereby minimizing the risk of pain [22]. The session
will begin with ten minutes of walking as a warm-up.
Next, hip flexion, extension, abduction and adduction
and knee flexion and extension motions will be con-
ducted in an open kinematic chain, along with a semi-
squat, aimed at strengthening the muscles of the lower
extremities [25]. Hip exercises will be conducted in the
supine (hip flexion and adduction), lateral (hip abduc-
tion) and prone (hip extension and knee flexion) posi-
tions. The semi-squat exercises will be conducted while
standing with up to 60 degrees of knee flexion and with
bilateral support. The concentric knee extension exer-
cises will be conducted with the volunteer seated. The
feet remained on the floor, maintaining an initial knee
angle of 70 degrees of flexion. They will be instructed to
extend the knee from 70 to 20 degrees of flexion, with-
out terminally extending the knee. The program will
consist of a total of 30 one-hour sessions, conducted
three times per week over ten weeks. At the end of each
training day, relaxation and cool-down exercises will be
performed.
The volunteers in control group will be instructed to
refrain from beginning any type of new physical activity
for a period of the study, maintaining the activities of
their normal daily lives.
After ten weeks, all the volunteers will be reevaluated
with the same tests and parameters conducted in the first
assessment. After this reevaluation, the groups will switch
and those women who had completed the exercise pro-
gram (experimental group) will now remain inactive.
Those women who had previously been inactive (control
group) will begin the same resistance program the
experimental group had performed (Figure 1).
RM calculation
In the first session, the maximum resistance test (RM)
will be conducted for each volunteer using the 1RM test
for knee extension and flexion. For the knee extension
test, the volunteer will be asked to sit on a standard
stretcher, in the same manner that was previously
described for the concentric knee extension exercise.
One leg weight of 1 kg will be placed on the ankle of
the dominant leg, and the volunteer will be instructed
to extend the knee fully, without changing or increasing
the speed of the motion, from the starting position of
90 degrees of flexion with the foot on the floor. A rest
period of five minutes will be given and the motion will
then be repeated with an increase of 1 or 2 kg, accord-
ing to the degree of difficulty reported by the volunteer.
The maximum load will be considered to be the weight
at which the volunteer is unable to perform the motion
to its fullest extent, shows signs of fatigue and/or
increases the speed of the motion, with no more than
five attempts made throughout the day. With the RM
established for knee extension, the work percentage will
be calculated. In the first six sessions, 50% of 1RM will
be used. Beginning with the seventh session, the load
used will be increased to 75% of 1RM [25]. Every two
weeks, or every six sessions, a new 1RM test will be
conducted to adjust the load. Three sets of eight repeti-
tions for each one of the exercises will be standardized
in relation to the workload, as described in previous stu-
dies [25].
For calculating the 1RM for the knee flexors, the
volunteer will be placed in the prone position and
instructed to flex the knee from 0 degrees to 45 degrees.
The same parameters as previously described in relation
to the load, interval and observation of the executed
motion will be considered in order to establish the RM
for the knee flexors. The same percentage of 50% and
75% of 1RM will be used for the work.
Procedures
Initially, the elderly women will answer a questionnaire
for inclusion in the study and to characterize the study
sample. Next, the elderly women were characterized as
frail, pre-frail or non-frail according to the criteria pro-
posed by Fried et al. (2001). Only those women classi-
fied as pre-frail will be invited to participate in the
training program. All participants will undergo the TUG
test [25,30,33], the 10MWT [34] and the knee extensor
muscle strength test. Participants will also be tested
with the isokinetic dynamometer at angular speeds of 60
and 180°/s and the plasma levels of IL-6 and TNF-a
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measured. All women will wear their everyday shoes or
those that they consider the most comfortable.
For conducting the TUG test, the volunteer will be
instructed to sit in a standard chair 45 cm in height
with arm supports at a height of 65 cm (using the floor
as a reference). At the verbal command “Are you ready?
Go” the participant will stand, walk three meters (pre-
viously marked on the floor), turn, return to the chair
and sit down again. A walking chronometer (Q & Q,
Japan CBM Corp) will begin timing the moment the
volunteer’s trunk no longer touches the back of the
chair, and will stop when the volunteer’s trunk returns
to leaning against the back of the chair. The displace-
ment time in seconds will be noted for analysis.
Next, the 10MWT will be conducted. The volunteer
will walk a course of ten meters (marked on a level
floor), with two meters for acceleration and two meters
for deceleration. The verbal command to begin will be
the same as that used for the TUG test. The chron-
ometer will begin as the volunteer passes the first two
acceleration meters and will stop when the ten meters
of the course are completed. The displacement time in
seconds will be used for analysis. The volunteer will be
instructed to walk at her normal pace.
To evaluate the knee extensor muscle strength, the volun-
teer will be positioned in the Biodex System 3 Pro® dynam-
ometer chair. Her trunk will remain supported at 80° of hip
flexion and will be secured with equipment positioning
belts. She will be instructed to exert a maximum force and
will be encouraged with handclaps and phrases such as
“Let’s go! Great. Don’t stop.” For each speed there will be a
practice drill with three repetitions for familiarization. The
test will be conducted by measuring five repetitions at an
angular speed of 60°/s and fifteen repetitions an angular
speeds of 180°/s, all at maximal effort, according to the
assessment protocol that has previously been described
[36]. The variables analyzed were the percentage of work
normalized to body weight, the peak torque in Newton per
meter (N/m) and the potential in watts (W).
The analysis of the plasma concentrations of IL-6 and
TNF-a will be conducted in a laboratory on a different
day than the functional and muscle strength measure-
ments. These exams will be conducted in the morning,
between 8:00 and 10:00 a.m., to guarantee that the circa-
dian rhythm does not influence the measurements [37,38].
The volunteer will be instructed to eat normally the day
before. A qualified professional will collect the blood, fol-
lowing the necessary patterns and procedures. Five millili-
ters of the collected blood will be centrifuged for 15
minutes and the plasma will be stored in a properly identi-
fied freezer (-70°C). Subsequently, duplicate analyses will
be conducted using an ELISA with high sensitivity kits
(Quantikine®HS, R&D Systems Minneapolis, USA) in
accordance with the manufacturer’s instructions and the
analysis protocol. The results will be presented as the
mean ± standard deviation.
Sample size
The sample size was calculated after a previous pilot study
with 12 participants, considering a confidence interval of
95%, a bilateral hypothesis test, a significance level of 0.05
(type I error), a power of 80% (type II error) and a cross-
over design for a statistical analysis of ANOVA. First, we
calculated the size effect (f) for the partial ANOVA for the
12 participants, according to Portner & Watkins [39]. We
use the functional performance (time in seconds of the
TUG). We considered two freedom degrees and a power
of 80%. It was determined that, considering a moderate
effect size (0.5) for a minimum clinically significant differ-
ence, 13 volunteers will be needed in each group.
Statistical analysis
The statistical analysis will be conducted using SPSS 15.0
in Windows. In order to verify data normality, the Sha-
piro-Wilk test will be used. A comparison of the variables
of muscle strength, functional capacity and plasma levels
of IL-6 and TNF-a, before and after the intervention and
three months after the completed intervention, will be
conducted using ANOVA. A post hoc analysis will be
conducted to find possible differences. A correlation
among the variables will be analyzed using the test of
Pearson’s correlation. An association among the variables
of IL-6 and TNF-a plasma levels, functional capacity and
muscle strength will be analyzed using a linear regres-
sion. The significance level will be p = 0.05.
Conclusions
In an attempt to better clarify the role of inflammatory
mediators in the aging process, our group previously
demonstrated the association among inflammatory med-
iators and functional outcomes and muscle strength in
elderly community residents and inpatients [39,40].
Similarly, the literature provides evidence of IL-6 release
after strenuous exercise in elderly persons and in youth.
This release may bring a benefit by decreasing TNF-a
levels [3,6-8,10,12,13]. However, the degree of intensity
and the activity load, as well as the mechanism of this
phenomenon, are not yet established. This trial was
designed in order to be reproducible in a research envir-
onment and the clinical setting. We expect to collect
results at the end of July 2010. We anticipate that the
results will have implications in the development of new
treatment strategies for elderly persons and the modifi-
cation of their frail conditions.
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